Literature DB >> 9405943

Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults.

S M Poutanen1, M Louie, A E Simor.   

Abstract

The medical records of 39 patients with Acinetobacter bacteremia identified in the period between 1985 and 1995 were reviewed. In 24 cases (62%) the bacteremia was considered to have been clinically significant. Most of the infections (79%) were nosocomial, and the majority of these were acquired in an intensive care unit. Ten (42%) patients developed septic shock complicating the bacteremia and 13 (54%) died. In most of these cases (85%), Acinetobacter bacteremia was thought to have caused or contributed to death. The following variables were associated with a greater risk of mortality: age > 65 years (OR = 16; p = 0.01); development of septic shock (OR = 22; p = 0.004); and the presence of coagulopathy (OR = 20; p = 0.03).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405943     DOI: 10.1007/bf01709254

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

3.  The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients.

Authors:  J F Timsit; V Garrait; B Misset; F W Goldstein; B Renaud; J Carlet
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

4.  Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital.

Authors:  W H Crombach; L Dijkshoorn; M van Noort-Klaassen; J Niessen; G van Knippenberg-Gordebeke
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

5.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

6.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

Review 7.  Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Strate; A Schulze; G Pulverer
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

Review 8.  Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings.

Authors:  P A Tilley; F J Roberts
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

Review 9.  Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.

Authors:  H Seifert; A Strate; G Pulverer
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

10.  Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis.

Authors:  R A Smego
Journal:  Arch Intern Med       Date:  1985-12
  10 in total
  8 in total

1.  Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.

Authors:  Stijn Blot; Koenraad Vandewoude; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

2.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 3.  Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

4.  Multidrug Resistance of Acinetobacter Baumannii in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria.

Authors:  G Odewale; O J Adefioye; J Ojo; F A Adewumi; O A Olowe
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-09-29

5.  Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?

Authors:  Aristine Cheng; Yu-Chung Chuang; Hsin-Yun Sun; Chia-Jui Yang; Hou-Tai Chang; Jia-Ling Yang; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany.

Authors:  Peter Klotz; Paul G Higgins; Andreas R Schaubmar; Klaus Failing; Ursula Leidner; Harald Seifert; Sandra Scheufen; Torsten Semmler; Christa Ewers
Journal:  Front Microbiol       Date:  2019-02-22       Impact factor: 5.640

7.  Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Baha Abdalhamid; Zeyad Alshibani; Khalid Awad; Abdullah Alzayed; Hoda Hassan; Mohammed Alsayiegh
Journal:  Case Rep Transplant       Date:  2012-08-07

8.  Multidrug-resistant Acinetobacter extremity infections in soldiers.

Authors:  Kepler A Davis; Kimberly A Moran; C Kenneth McAllister; Paula J Gray
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.